Health AI Central
Share:
Peer-Reviewed Publication
Front Oncol2026;161737940.January 1, 2026Journal Article

Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomography.

Hubert Beaumont1, Antoine Iannessi1, Thomas Louis2, Serena Pacile2, Pierre Fillard2
1Independent Researcher, Valbonne, France.
2Therapixel, Paris, France.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Full-field digital mammography (FFDM) is the standard for breast cancer screening. Digital breast tomosynthesis (DBT), compared to FFDM, enhances cancer detection and reduces unnecessary biopsies. Despite DBT's adoption, critical questions remain-higher radiation, time, cost, and clinical benefits, particularly for systematic breast screening. In the era of AI computer-aided detection/…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.